ES2084168T3 - Composiciones antimalaricas. - Google Patents
Composiciones antimalaricas.Info
- Publication number
- ES2084168T3 ES2084168T3 ES91911449T ES91911449T ES2084168T3 ES 2084168 T3 ES2084168 T3 ES 2084168T3 ES 91911449 T ES91911449 T ES 91911449T ES 91911449 T ES91911449 T ES 91911449T ES 2084168 T3 ES2084168 T3 ES 2084168T3
- Authority
- ES
- Spain
- Prior art keywords
- antimalary
- antimalaric
- compositions
- agent
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA INVENCION DESCRIBE UNA COMPOSICION ANTIMALARIA SINERGISTICAS QUE COMPRENDE EL AGENTE ANTIMALARIA BENFLUMETOL Y TAMBIEN UN AGENTE ANTIMALARIA DEL GRUPO ARTEMISININA TAL COMO ARTEMETERO. LA COMPOSICION SE PUEDE FORMULAR EN FORMAS DE DOSIS SOLIDAS TAL COMO TABLETAS Y ES UTIL PARA EL TRATAMIENTO DE MALARIA RESISTENTE A LOS MEDICAMENTOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN90106722A CN1058717A (zh) | 1990-08-08 | 1990-08-08 | 抗疟新药—复方蒿甲醚及其制备方法 |
CN91102575A CN1085527C (zh) | 1990-08-08 | 1991-04-24 | 增效复方抗疟药本芴醇的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2084168T3 true ES2084168T3 (es) | 1996-05-01 |
Family
ID=25742651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91911449T Expired - Lifetime ES2084168T3 (es) | 1990-08-08 | 1991-06-05 | Composiciones antimalaricas. |
Country Status (27)
Country | Link |
---|---|
US (1) | US5677331A (es) |
EP (1) | EP0500823B1 (es) |
JP (1) | JP2562857B2 (es) |
KR (1) | KR100221689B1 (es) |
CN (2) | CN1058717A (es) |
AP (1) | AP231A (es) |
AT (1) | ATE135209T1 (es) |
AU (1) | AU642747B2 (es) |
CA (1) | CA2065285C (es) |
DE (2) | DE69117922T2 (es) |
DK (1) | DK0500823T3 (es) |
EG (1) | EG19905A (es) |
ES (1) | ES2084168T3 (es) |
FI (1) | FI921491A0 (es) |
GR (1) | GR3019313T3 (es) |
HK (1) | HK1000312A1 (es) |
HU (1) | HU227345B1 (es) |
IE (1) | IE72095B1 (es) |
IL (1) | IL98463A (es) |
LU (1) | LU90844I2 (es) |
MA (1) | MA22176A1 (es) |
NL (1) | NL300048I2 (es) |
NZ (1) | NZ238477A (es) |
PT (1) | PT97945B (es) |
SA (1) | SA91120263B1 (es) |
WO (1) | WO1992002217A1 (es) |
ZA (1) | ZA914490B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637594A (en) * | 1991-04-11 | 1997-06-10 | Ciba Geigy Corporation | Antimalarial synergistic compositions containing benflumetol |
WO1993015727A1 (en) * | 1992-02-07 | 1993-08-19 | Ciba-Geigy Ag | Antimalarial synergistic compositions containing benflumetol |
WO1995027964A1 (en) * | 1994-04-12 | 1995-10-19 | Qualcomm Incorporated | Method and apparatus for freight transportation using a satellite navigation system |
US5657088A (en) * | 1995-12-22 | 1997-08-12 | Cirrus Logic, Inc. | System and method for extracting caption teletext information from a video signal |
US6136847A (en) * | 1996-12-02 | 2000-10-24 | Johns Hopkins University | Water-soluble trioxanes as potent and safe antimalarial agents |
CH692321A5 (de) | 1997-11-03 | 2002-05-15 | Mepha Ag | Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält. |
CO5040050A1 (es) * | 1998-06-25 | 2001-05-29 | Novartis Ag | Compuestos de 2-amino-1-(9-arilmetilidina-2,7-dicloro-9h- fluoren-4-ilo)-etanoles n-sustituidos, procedimientos para su obtencion y preparados farmaceuticos que los contienen . |
IN191696B (es) * | 1999-02-12 | 2003-12-20 | Council Scient Ind Res | |
AU2000255631A1 (en) * | 2000-03-31 | 2001-10-15 | Council Of Scientific And Industrial Research | A synergistic anti-malarial formulation |
WO2002032905A1 (fr) * | 2000-10-20 | 2002-04-25 | Ajinomoto Co.,Inc. | Compositions medicamenteuses, dose et procede de traitement du paludisme |
US7842719B2 (en) * | 2002-10-31 | 2010-11-30 | Kemin Foods, L.C. | Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus |
WO2004075817A2 (en) * | 2003-02-26 | 2004-09-10 | Vrije Universiteit Brussel | Suspendable pharmaceutical composition |
WO2005023304A2 (en) * | 2003-09-04 | 2005-03-17 | Cipla Limited | Antimalarial compositions and manufacturing process thereof |
US20110206636A1 (en) * | 2003-09-16 | 2011-08-25 | Kemin Foods, LLC | Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus |
WO2007017646A2 (en) * | 2005-08-05 | 2007-02-15 | Cipla Limited | Anti-malarial composition comprising artesunate and lumefantrine |
WO2007036947A1 (en) * | 2005-09-30 | 2007-04-05 | Ipca Laboratories Limited | Delayed release anti-malarial composition |
US20090324715A1 (en) * | 2006-06-26 | 2009-12-31 | Sumit Madan | High dose oral pharmaceutical compositions of artemether and lumefantrine |
CN100463669C (zh) * | 2006-08-31 | 2009-02-25 | 广州市医药工业研究所 | 复方蒿甲醚自乳化剂 |
WO2008098586A1 (en) * | 2007-02-13 | 2008-08-21 | Dafra Pharma N.V. | Pharmaceutical carrier composition and pharmaceutical composition |
CH700941B1 (de) * | 2007-12-04 | 2010-11-15 | Mepha Ag | Pharmazeutische Zusammensetzung zur Behandlung von Malaria. |
FR2926993B1 (fr) * | 2008-02-06 | 2011-03-11 | Sanofi Aventis | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
WO2010004573A1 (en) * | 2008-07-07 | 2010-01-14 | Ipca Laboratories Limited | Synergistic antimalarial pharmaceutical composition |
EA025956B1 (ru) * | 2012-03-30 | 2017-02-28 | Зюдцукер Акциенгезелльшафт Маннхайм/Окзенфурт | Порошкообразная присыпка для нанесения на поверхность материала ядра жевательной резинки |
CN103251584A (zh) * | 2013-05-09 | 2013-08-21 | 西安力邦制药有限公司 | 注射用蒿甲醚/本芴醇复方脂肪乳的制备及其在疟疾治疗中的应用 |
WO2015140709A1 (en) * | 2014-03-19 | 2015-09-24 | Novartis Ag | Solid pharmaceutical dosage forms |
CN110691597A (zh) | 2017-04-24 | 2020-01-14 | 诺华股份有限公司 | 2-氨基-1-(2-(4-氟苯基)-3-(4-氟苯基氨基)-8,8-二甲基-5,6-二氢咪唑并[1,2-a]吡嗪-7(8H)-基)乙酮及其组合的治疗方案 |
CN113599382B (zh) * | 2021-08-20 | 2023-01-03 | 兰州大学 | 喹啉类衍生物在制备治疗糖尿病及其并发症药物中的应用 |
CN116747218B (zh) * | 2023-08-21 | 2023-10-31 | 山东省中医药研究院 | 百秋李醇、百秋李醇复合抗疟组合物及制备抗疟原虫药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85100781B (zh) * | 1985-04-01 | 1988-07-06 | 广西壮族自治区桂林制药厂 | 抗疟药物青蒿酯的制备方法 |
CN85100978A (zh) * | 1985-04-01 | 1986-08-13 | 中医研究院中药研究所 | 还原青蒿素的生产工艺 |
CN87101346A (zh) * | 1987-06-09 | 1988-03-09 | 山东省中医药研究所 | 青蒿素提取工艺 |
DE68906345T2 (de) * | 1988-10-07 | 1993-10-28 | Hoechst Ag | Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten. |
CN1029680C (zh) * | 1988-11-10 | 1995-09-06 | 军事医学科学院微生物流行病研究所 | 抗疟新药苯芴醇的合成新工艺 |
-
1990
- 1990-08-08 CN CN90106722A patent/CN1058717A/zh not_active Withdrawn
-
1991
- 1991-04-24 CN CN91102575A patent/CN1085527C/zh not_active Expired - Lifetime
- 1991-06-05 JP JP3510033A patent/JP2562857B2/ja not_active Expired - Lifetime
- 1991-06-05 AU AU79549/91A patent/AU642747B2/en not_active Expired
- 1991-06-05 HU HU9201528A patent/HU227345B1/hu unknown
- 1991-06-05 CA CA002065285A patent/CA2065285C/en not_active Expired - Lifetime
- 1991-06-05 ES ES91911449T patent/ES2084168T3/es not_active Expired - Lifetime
- 1991-06-05 EP EP91911449A patent/EP0500823B1/en not_active Expired - Lifetime
- 1991-06-05 KR KR1019920700800A patent/KR100221689B1/ko not_active IP Right Cessation
- 1991-06-05 DE DE69117922T patent/DE69117922T2/de not_active Expired - Lifetime
- 1991-06-05 WO PCT/EP1991/001033 patent/WO1992002217A1/en active IP Right Grant
- 1991-06-05 AT AT91911449T patent/ATE135209T1/de not_active IP Right Cessation
- 1991-06-05 DK DK91911449.6T patent/DK0500823T3/da active
- 1991-06-05 DE DE2001199038 patent/DE10199038I2/de active Active
- 1991-06-10 MA MA22451A patent/MA22176A1/fr unknown
- 1991-06-11 NZ NZ238477A patent/NZ238477A/xx not_active IP Right Cessation
- 1991-06-11 EG EG35991A patent/EG19905A/xx active
- 1991-06-12 AP APAP/P/1991/000275A patent/AP231A/en active
- 1991-06-12 IE IE198991A patent/IE72095B1/en not_active IP Right Cessation
- 1991-06-12 ZA ZA914490A patent/ZA914490B/xx unknown
- 1991-06-12 PT PT97945A patent/PT97945B/pt not_active IP Right Cessation
- 1991-06-12 IL IL9846391A patent/IL98463A/en not_active IP Right Cessation
- 1991-12-10 SA SA91120263A patent/SA91120263B1/ar unknown
-
1992
- 1992-04-03 FI FI921491A patent/FI921491A0/fi unknown
-
1994
- 1994-03-23 US US08/216,440 patent/US5677331A/en not_active Expired - Lifetime
-
1996
- 1996-03-14 GR GR960400492T patent/GR3019313T3/el unknown
-
1997
- 1997-09-29 HK HK97101870A patent/HK1000312A1/xx not_active IP Right Cessation
-
2001
- 2001-07-19 NL NL300048C patent/NL300048I2/nl unknown
- 2001-07-19 LU LU90844C patent/LU90844I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2084168T3 (es) | Composiciones antimalaricas. | |
MX9202328A (es) | Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo. | |
AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
AR065970A2 (es) | Una composicion farmaceutica oral solida que comprende una combinacion de metformin y glibenclamida y uso de dicha composicion | |
UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
ES2039278T3 (es) | Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides. | |
ES2158988T3 (es) | Composiciones de aerosol. | |
AR029806A1 (es) | Derivados de fenilo, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de la composicion farmaceutica y usos de estos derivados | |
AR007614A1 (es) | Compuesto derivado de amidino, formulacion farmaceutica que lo incluye, metodos para la elaboracion de medicamentos que contienen a dicho compuesto, yproceso para la preparacion de dicho compuesto. | |
ES2185760T3 (es) | Composicion farmaceutica para el tratamiento del herpes. | |
PE20020348A1 (es) | Exemestano como agente quimiopreventivo | |
AR247984A1 (es) | Metodo para la preparacion de una composicion sinergica que tiene actividad antiplaca o antigingivitis | |
ES2101252T3 (es) | Inhibidores de la proteasa del hiv utiles para el tratamiento del sida. | |
ES2080063T3 (es) | Composiciones sinergicas que contienen imazalil. | |
ES2195939T3 (es) | Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba. | |
CO4130200A1 (es) | Inhibidores de proteasa del hiv utiles en el tratamiento del sida | |
ES2032393T3 (es) | Metodo para producir un preparado acuoso. | |
ES2036670T3 (es) | Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante. | |
AR028987A1 (es) | Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad | |
ES2062997T3 (es) | Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento. | |
AR022017A1 (es) | Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica | |
AR021491A1 (es) | Un compuesto de 6-azauracilo que inhibe a il-5, una composicion que lo comprende, un proceso para preparar dicha composicion, y el uso de dicho compuestopara la manufactura de un medicamento y de un agente de diagnostico | |
ES2058874T3 (es) | 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen. | |
ES2121109T3 (es) | Composicion de champu. | |
ES2033181B1 (es) | Una tableta o capsula de herbicida para su aplicacion en arrozales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 500823 Country of ref document: ES |
|
SPCF | Request for supplementary protection certificate filed |
Free format text: ARTEMETER + LUMEFENTRINA (RIAMET) Spc suppl protection certif: C200100033 Filing date: 20010926 |
|
SPCG | Supplementary protection certificate granted |
Free format text: ARTEMETER + LUMEFENTRINA (RIAMET) Spc suppl protection certif: C200100033 Filing date: 20010926 Expiry date: 20141130 Effective date: 20031222 |